Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed

Permanent URI for this communityhttps://hdl.handle.net/20.500.14719/1741

Browse

Search Results

Now showing 1 - 5 of 5
  • PublicationOpen Access
    Endocrine Surgery during the COVID-19 Pandemic: Recommendations from the Turkish Association of Endocrine Surgery
    (2020) Teksöz, Serkan; Sormaz, İsmail Cem; İçöz, Recep Gökhan; Makay, Özer; Dural, Ahmet Cem; Hacıyanlı, Mehmet; Şahbaz, Nuri Alper; İşcan, Yalın; Soylu, Selen; Aygün, Nurcihan; İşgör, Adnan; Özdemir, Murat; Aydın, Oğuz Uğur ; Tunca, Fatih; Şenyürek, Yasemin; Uludağ, Mehmet Emin; Emre, Ali Uğur; İstanbul Üniversitesi - Cerrahpaşa; İstanbul Üniversitesi; Ege Üniversitesi; Ege Üniversitesi; Sağlık Bilimleri Üniversitesi; İzmir Katip Çelebi Üniversitesi; Sağlık Bilimleri Üniversitesi; İstanbul Üniversitesi; T.C. Sağlık Bakanlığı; Sağlık Bilimleri Üniversitesi; Bahçeşehir Üniversitesi; Ege Üniversitesi; T.C. Sağlık Bakanlığı; İstanbul Üniversitesi; İstanbul Üniversitesi; Sağlık Bilimleri Üniversitesi; T.C. Sağlık Bakanlığı
    The 2019 novel coronavirus disease (COVID-19) was initially seen in Wuhan, China, in December 2019. World Health Organizationclassified COVID-19 as a pandemic after its rapid spread worldwide in a few months. With the pandemic, all elective surgeries andnon-emergency procedures have been postponed in our country, as in others. Most of the endocrine operations can be postponedfor a certain period. However, it must be kept in mind that these patients also need surgical treatment, and the delay time shouldnot cause a negative effect on the surgical outcome or disease process. It has recently been suggested that elective surgical interventionscan be described as medically necessary, time-sensitive (MeNTS) procedures.Some guidelines have been published on proper and safe surgery for both the healthcare providers and the patients after theimmediate onset of the COVID-19 pandemic. We should know that these guidelines and recommendations are not meant toconstitute a position statement, the standard of care, or evidence-based/best practice. However, these are mostly the opinionsof a selected group of surgeons. Generally, only life-threatening emergency operations should be performed in the stage wherethe epidemic exceeds the capacity of the hospitals (first stage), cancer and transplantation surgery should be initiated when theoutbreak begins to be controlled (second stage), and surgery for elective cases should be performed in a controlled manner withsuppression of the outbreak (third stage).In this rapidly developing pandemic period, the plans and recommendations to be made on this subject are based on expert opinionsby considering factors, such as the course and biology of the disease, rather than being evidence-based. In the recent reportsof many endocrine surgery associations and in various reviews, it has been stated that most of the cases can be postponed to thethird stage of the epidemic.We aimed to evaluate the risk reduction strategies and recommendations that can help plan the surgery, prepare for surgery, protectboth patients and healthcare workers during the operation and care for the patients in the postoperative period in endocrine surgery.
  • PublicationOpen Access
    Surgical Indications and Techniques for Adrenalectomy
    (2020) Aygün, Nurcihan; Uludağ, Mehmet; İşgör, Adnan; T.C. Sağlık Bakanlığı; T.C. Sağlık Bakanlığı; Bahçeşehir Üniversitesi
    Indications for adrenalectomy are malignancy suspicion or malignant tumors, non-functional tumors with the risk of malignancyand functional adrenal tumors. Regardless of the size of functional tumors, they have surgical indications. The hormone-secretingadrenal tumors in which adrenalectomy is indicated are as follows: Cushing’s syndrome, arises from hypersecretion of glucocorticoidsproduced in fasciculata adrenal cortex, Conn’s syndrome, arises from an hypersecretion of aldosterone produced by glomerulosaadrenal cortex, and Pheochromocytomas that arise from adrenal medulla and produce catecholamines. Sometimes, bilateral adrenalectomy may be required in Cushing's disease due to pituitary or ectopic ACTH secretion. Adenomas arise from the reticularis layerof the adrenal cortex, which rarely releases too much adrenal androgen and estrogen, may also develop and have an indication foradrenalectomy. Adrenal surgery can be performed by laparoscopic or open technique. Today, laparoscopic adrenalectomy is the goldstandard treatment in selected patients. Laparoscopic adrenalectomy can be performed transperitoneally or retroperitoneoscopically. Both approaches have their advantages and disadvantages. In the selection of the surgery type, the experience and habits ofthe surgeon are also important, along with the patient’s characteristics. The most common type of surgery performed in the worldis laparoscopic transabdominal lateral adrenalectomy, which most surgeons are more familiar with. The laparoscopic anterior transperitoneal approach is the least preferred laparoscopic method in adrenalectomy. Retroperitoneal laparoscopic adrenalectomy canbe performed with a posterior or lateral approach. In addition to conventional laparoscopy, laparoscopic surgery is robot-assisted,which can be administered by transperitoneal or retroperitoneal approach. In addition, conventional or robot-assisted laparoscopicadrenalectomy can be performed transabdominally or retroperitoneally using the single-port method. Today, partial adrenalectomycan be performed using laparoscopic techniques in bilateral adrenal masses, hereditary diseases with the risk of developing multipleadrenal tumors, and solitary masses of the adrenal gland. Open surgery is indicated in the case of malignancy or suspected malignancy and large tumors when laparoscopic surgery is contraindicated. The risk of conversion to open surgery is low (approximately 5%).The open transperitoneal anterior approach is the most common open intervention, especially in large tumors with malignancy orsuspected malignancy. This procedure can be performed using a midline incision, bilateral or unilateral subcostal incision, Makuuchior modified Makuuchi incision. Thoracoabdominal incision may be required, especially in the removal of large malignant lesions as ablock. The open retroperitoneal approach can be applied posteriorly or laterally.
  • PublicationOpen Access
    Parathyroidectomy Results in Primary Hyperparathyroidism:Analysis of the Results From a Single Center
    (2021) Yetkin, Gürkan; Aygün, Nurcihan; Uludağ, Mehmet; İşgör, Adnan; Akgün, İsmail Ethem; Ünlü, Mehmet Taner; Erol, Rümeysa Selvinaz; Sağlık Bilimleri Üniversitesi; Sağlık Bilimleri Üniversitesi; Sağlık Bilimleri Üniversitesi; Bahçeşehir Üniversitesi; Sağlık Bilimleri Üniversitesi; T.C. Sağlık Bakanlığı; Sağlık Bilimleri Üniversitesi
    Objectives: The curative treatment of primary hyperparathyroidism (PHPT) is surgery. Persistent and recurrent disease may de velop after surgical treatment. In this study, we aimed to evaluate the surgical cure rate in patients who underwent surgery forPHPT in our clinic. Methods: The data of patients who underwent parathyroidectomy for PHPT by two experienced surgeons between 2000 and2015 in our clinic were retrospectively evaluated. Patients who were followed for at least 6 months after their first parathyroidec tomy were included in the study. Surgical cure and persistent and recurrent disease rates were evaluated in patients. Results: During this period, 368 interventions were performed in 357 patients (293 F and 64 M) who were operated for PHPT inour clinic, with a mean age of 54.9±13.1 years. In the first surgery, 116 patients (32.5%) had bilateral neck exploration, 251 patients(67.5%) had unilateral neck exploration (UNE) or focused parathyroid surgery (FPS). In the first operation, 343 patients (96.1%) hadcure, 14 patients (13 F and 1 M) remained persistent. Secondary surgical intervention was performed in 11 patients. UNE or FPS wasperformed to 10 patients (90.9%), partial sternotomy was performed to one patient. Ten of the patients had cure. Three of these pa tients had a solitary parathyroid adenoma that was not removed in the first surgery, and seven patients had a second adenoma. Fourpatients remained persistent (1.1%). Recurrent disease developed in four patients during follow-up (1.1%). Total cure rate was 97.8%. Conclusion: The only definitive treatment for PHPT is surgery. High surgical cure can be achieved by pre-operative evaluationand appropriate surgical planning. However, persistent PHPT may develop, especially due to double adenoma or ectopic location.Patients with persistent PHPT can be evaluated with repeat imaging methods and with appropriate surgical planning, a high curerate can be obtained in secondary surgery, which can increase the total surgical cure rate. Recurrence rate is rare.
  • PublicationOpen Access
    Non-Toxic Multinodular Goiter: From Etiopathogenesis to\rTreatment
    (2022) Ünlü, Mehmet Taner; Aygün, Nurcihan; Uludağ, Mehmet; Köstek, Mehmet; İşgör, Adnan; Sağlık Bilimleri Üniversitesi; Sağlık Bilimleri Üniversitesi; Sağlık Bilimleri Üniversitesi; Sağlık Bilimleri Üniversitesi; Bahçeşehir Üniversitesi
    Goiter term is generally used for defining the enlargement of thyroid gland. Thyroid nodules are very common and some of these\rnodules may harbor malignancy. Multinodular goiter (MNG) disease without thyroid dysfunction is defined as non-toxic MNG.\rThere are many factors in etiology for development of MNG. They can be classified as iodine dependent and non-iodine dependent\rfactors basically. Beyond this basic classification, the effect of many environmental and acquired factors is also effective on the\rdevelopment of goiter.\rMany methods have described for diagnosis and treatment for non-toxic MNG. Biochemical tests, imagining methods, invasive and\rnon-invasive methods have been used for diagnosis for many years. Each method has advantages and disadvantages, separately.\rAlthough the best method for diagnosis is still debatable, distinguishing malignant nodules from benign nodules is the first and\rmost important step for MNG.\rBiochemical tests such as serum thyroid stimulating hormone (TSH) measurement, thyroid hormone measurement, and thyroid\rultrasonography are used for diagnosis of MNG, traditionally. Nowadays, there are some new techniques were developed like\rultrasound-elastography. Furthermore, thyroid scintigraphy may be used if there is abnormal TSH measurement. Fine-needle as-\rpiration biopsy and some cross-sectional imaging methods (computed tomography, magnetic resonance imaging, and positron\remission tomography) could be used, too.\rAfter a certain diagnosis is made, treatment options should be evaluated. Many treatment methods have been used for goiter\rfrom ancient times upon today. From non-invasive methods such as medical follow-up to invasive methods such as lobectomy\ror thyroidectomy are options for treatment. Patients with compression symptoms due to an enlarged thyroid gland are usually\rcandidates for surgery. In this study, it is aimed to determine the most appropriate treatment for the patient by discussing the\radvantages and disadvantages of all these methods.\rThe present review discusses definition of goiter term, etiology, epidemiology, pathogenesis, diagnostic methods, and treatment\rmethods for nontoxic MNG.\r
  • PublicationOpen Access
    Substernal Goiter: From Definitions to Treatment
    (2022) Aygün, Nurcihan; Uludağ, Mehmet; İşgör, Adnan; Köstek, Mehmet; Ünlü, Mehmet Taner; Sağlık Bilimleri Üniversitesi; Sağlık Bilimleri Üniversitesi; Bahçeşehir Üniversitesi; Sağlık Bilimleri Üniversitesi; Sağlık Bilimleri Üniversitesi
    The enlargement of multinodular goiter into the mediastinum through the thoracic inlet or ectopic thyroid tissues directly in the \rmediastinum is defined as Substernal Goiter (SG). However, there is no clear consensus in the literature on this definition. There \rare many definitions for SG in the literature. Most definitions are similar or overlapping. Since the thyroid is located in the neck \rabove the thoracic inlet in its normal anatomical position, the simplest clinical definition should be preferred among the definitions regarding its descent below the thoracic inlet and adjacent to the mediastinal organs. In the American Thyroid Association \rguideline, SG is defined as clinical or radiological protrusion of the thyroid gland over the sternal notch or clavicle in a patient with \ra slightly extended neck in the supine position. SGs can be classified as primary or secondary according to their origins. In addition, there are combined SGs resulting from the enlargement of the primary SG, which is the growth of the cervical thyroid gland \rtoward the mediastinum, and the secondary SG, which is defined as an ectopic mediastinal mass, together. We find it appropriate \rto define such SGs as mixed SGs. In this disease, which has the same etiology and etiopathogenesis as cervical goiter, the descent \rof the thyroid gland into the mediastinum due to some anatomical factors explains the physiopathology. Compression symptoms \rof mediastinal major vascular structures, trachea, and esophagus cause the symptoms and findings of SGs due to its localization. \rIn addition, the relationship of SGs with possible malignancy risk and hyperthyroidism affecting the indications and methods of \rtreatment has been discussed for a long time. In this study, we aimed to evaluate the definitions, classification, physiopathology, \rlaboratory and imaging methods used for diagnosis, the relationship of SG with hyperthyroidism and malignancy, and briefly the \rtreatment methods, according to the current studies from literature.